New Hope For Pediatric Leukemia Patients

Cincinnati Children’s Hospital Medical Center will soon be getting a newly-approved drug that uses the body’s own immune system to fight cancer.

Kymriah, also known as CAR T-cell therapy, takes a patient’s own immune cells and reprograms them to fight acute lymphocytic leukemia (ALL).

To find out how the drug is providing new hope for leukemia patients, click on WVXU.